This finding concurs with the previous findings that inhibiting HIF-1α can enhance the sensitivity to chemotherapeutic agents in cancer cells such as fibrosarcoma, gastric cancer, and breast carcinoma [21]–[23]. The gene discussed is HIF1A; the disease is cancer.